Vaxcyte, Inc. (PCVX)
Company Info
Highlights
$4.44B
-$3.80
-$7.98M
-$345.48M
$27.66 - $121.06
$132.00
10.83%
3.65
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Vaxcyte, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Vaxcyte, Inc. had a return of -59.78% year-to-date (YTD) and -45.78% in the last 12 months.
PCVX
-59.78%
-52.61%
-70.85%
-45.78%
N/A
N/A
^GSPC (Benchmark)
-6.06%
-1.00%
-4.87%
8.34%
14.11%
10.27%
Monthly Returns
The table below presents the monthly returns of PCVX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 7.89% | -17.32% | -48.29% | -12.82% | -59.78% | ||||||||
| 2024 | 13.73% | 3.36% | -7.46% | -11.36% | 16.05% | 7.46% | 4.48% | 2.37% | 41.49% | -6.93% | -11.29% | -13.23% | 30.35% |
| 2023 | -5.42% | -9.66% | -8.52% | 14.27% | 15.62% | 0.85% | -3.76% | 8.03% | -1.81% | -5.65% | 7.63% | 21.31% | 30.97% |
| 2022 | -19.97% | 21.69% | 4.23% | 0.25% | -0.91% | -9.30% | 6.07% | 13.34% | -8.26% | 81.71% | 5.62% | 4.10% | 101.56% |
| 2021 | -7.68% | -3.95% | -16.17% | -5.97% | 13.46% | 6.83% | -3.69% | 20.99% | -3.28% | -7.77% | -12.91% | 16.73% | -10.46% |
| 2020 | 20.88% | -0.63% | 44.16% | 9.05% | -24.32% | -14.10% | -17.23% | 1.61% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of PCVX is 16, meaning it’s performing worse than 84% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Vaxcyte, Inc. (PCVX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Vaxcyte, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Vaxcyte, Inc. was 76.22%, occurring on Apr 10, 2025. The portfolio has not yet recovered.
The current Vaxcyte, Inc. drawdown is 72.09%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -76.22% | Oct 17, 2024 | 120 | Apr 10, 2025 | — | — | — |
| -70.31% | Sep 24, 2020 | 157 | May 10, 2021 | 649 | Dec 6, 2023 | 806 |
| -33.91% | Aug 21, 2020 | 12 | Sep 8, 2020 | 10 | Sep 22, 2020 | 22 |
| -25.9% | Feb 28, 2024 | 41 | Apr 25, 2024 | 52 | Jul 11, 2024 | 93 |
| -25.25% | Jun 22, 2020 | 17 | Jul 15, 2020 | 18 | Aug 10, 2020 | 35 |
Volatility
Volatility Chart
The current Vaxcyte, Inc. volatility is 67.04%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |